Teleflex Incorporated (Teleflex or 'the company') offers specialty medical devices for a range of procedures in critical care and surgery. The company sells its products to hospitals and healthcare providers in more than 150 countries across the globe.

The company conducts its operations through six reportable segments: EMEA (Europe, the Middle East and Africa), Vascular North America, Asia, Anesthesia North America, Surgical North America, and OEM.

Teleflex's EMEA segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The products of the EMEA segment are used in the acute care settings for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications, including urology.

The company’s Vascular North America segment is comprised of North American vascular and interventional access businesses. In its Vascular North America segment, the company's vascular access products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure and taking of blood samples through a single puncture site. The company's vascular access devices, which are primarily catheters and related devices, principally consist of products such as ARROW central venous catheters, or CVCs, Arrow EZ-IO system, ARROW jugular axillo-subclavian central catheters (JACCs), ARROW peripherally inserted central catheters (PICCs), VPS G4 Vascular Positioning System, VPS G4 Vascular Positioning System, ARROW arterial catheterization sets, and ARROW percutaneous sheath introducers.

Teleflex also offers many of its vascular access catheters in a Maximal Barrier Precautions Tray. The tray is available for CVCs, PICCs and multi access catheters (MAC) and includes a full body drape, coated or non-coated catheter and other accessories.

The company’s interventional access products are used in a range of applications, including dialysis, oncology and critical care therapies. Its interventional access portfolio also includes several arrow branded products, such as diagnostic and drainage kits, embolectomy balloons, and reinforced percutaneous sheath introducers. Its interventional access products include Arrow OnControl Powered Bone Marrow / Bone Access System, Arrow Trerotola Percutaneous Thrombectomy Device (PTD), Arrow Chronic Hemodialysis Catheters, and Arrow Acute Hemodialysis Catheters.

The company's Anesthesia North America segment is comprised of North American airway management and pain management businesses.

Airway management products and related devices consist of LMA airways, LMA atomization, and RUSCH endotracheal tubes and laryngoscopes. Portfolio of pain management products manufactured by the company includes Arrow Epidural catheters and trays, Arrow Peripheral Nerve Block (PNB) products, AutoFuser disposable pain pumps, and Arrow EZ-IO system.

The company's Surgical North America segment offers surgical products, which are designed to provide surgeons with a range of devices for use in a variety of surgical procedures. Its portfolio consists of both single-use and reusable products, including WeckLigation Systems; Weck EFx Fascial Closure System; and Percutaneous Surgical Systems. Teleflex’s other branded surgical products include Weck Vista bladeless access ports, Deknatel sutures and Pilling and Kmedic surgical instruments.

The OEM segment of Teleflex designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company's OEM segment, which includes the TFX OEM and Deknatel OEM brands, provides custom-engineered extrusions, diagnostic and interventional catheters, sheath/dilator sets (introducers) and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company offers an extensive portfolio of integrated capabilities, including engineering, material selection, regulatory affairs, prototyping, testing and validation, manufacturing, assembly and packing. The OEM segment also offers balloons and balloon catheters.

In addition, the company has 'all other' business that offers single-use respiratory, urology and cardiac care products, as well as capital equipment, which are provided to hospitals and other alternative channels of care. “All other" line item also includes the company’s Latin American business. The company’s respiratory products are used in a variety of care settings and include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products. Its urology product portfolio provides bladder management for patients in the hospital and individuals in the home care markets. The product portfolio consists principally of a range of catheters (including Foley, intermittent, external and suprapubic), urine collectors, catheterization accessories and products for operative endourology marketed under the Rusch brand name.

The company’s cardiac care product portfolio includes diagnostic and intra-aortic balloon catheters and capital equipment. Its Latin America business generally engages in the same type of operations, and serves the same type of end markets, as the EMEA and Asia segments.

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of Teleflex Incorporated in terms of revenue, net income, and operating income.

-- Financials - Details about Teleflex Incorporated listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines Teleflex Incorporated’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases Teleflex Incorporated’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of Teleflex Incorporated’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does Teleflex Incorporated operate and what are key points about it?

-- What is the product / service portfolio of Teleflex Incorporated?

-- How has Teleflex Incorporated performed financially from the 2013?

-- How does Teleflex Incorporated rank among its peers in terms of revenue and market share?

-- What are Teleflex Incorporated strengths and weaknesses and what opportunities and threats does it face?

-- What are Teleflex Incorporated’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of Teleflex Incorporated? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics